13 Nov 2025 | 5 Mins Read
Lincoln Pharma shares decline on 24% Q2 profit drop
Flipitmoney
Shares of Lincoln Pharmaceuticals Ltd. are trading lower on Thursday, November 13. Lincoln Pharmaceuticals Ltd.'s net profit declined 24% year-on-year to ₹20 crore in the September quarter. Revenue rose 1.4% to ₹163.4 crore. EBITDA fell 10.2% to ₹25.4 crore and the EBITDA margin slipped to 15.5%. Shares are trading 2.05% lower at ₹518.95 and have declined 40% in 2025.